The Foodstuff and Drug Administration initially authorised the injectable medication for treating diabetic issues in 2017; the agency accredited a drug with the next dose from the Lively ingredient in copyright, termed semaglutide, to treat obesity in 2021, beneath the brand name Wegovy. Since then, talk on the drug has https://julianz047cjk9.magicianwiki.com/user